Longitudinal Study of Symptoms in Colorectal Cancer
NCT00777192 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 509
Last updated 2019-05-29
Summary
The goal of this research study is to learn more about the pain and/or other symptoms that patients may experience within five years from CRC diagnosis. Researchers also want to learn how genetic differences may affect the symptoms patients experience from cancer and cancer therapy.
Conditions
Interventions
- BEHAVIORAL
-
Questionnaires
20 Minute Questionnaires beginning Visit 1, to measure pain/other symptoms, mood, and quality of life
Sponsors & Collaborators
- collaborator INDUSTRY
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Xin Shelley Wang, MD. MPH · M.D. Anderson Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-08-31
- Primary Completion
- 2018-12-27
- Completion
- 2018-12-27
Countries
- United States
Study Locations
More Related Trials
-
Chemotherapy and Cetuximab in Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer
NCT00766142 ·Status: TERMINATED ·Phase: PHASE2
-
S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer
NCT00686166 ·Status: COMPLETED ·Phase: PHASE2
-
Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine
NCT00003522 ·Status: TERMINATED ·Phase: PHASE2
-
Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer
NCT00408772 ·Status: WITHDRAWN ·Phase: PHASE2
-
Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum
NCT00086931 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer
NCT00120172 ·Status: TERMINATED ·Phase: PHASE2
-
Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer
NCT00208546 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
NCT01280643 ·Status: TERMINATED ·Phase: NA
-
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
NCT00098787 ·Status: COMPLETED ·Phase: PHASE2
-
GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin
NCT00044343 ·Status: COMPLETED ·Phase: PHASE2
-
TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer
NCT04294264 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Azacitidine and CAPOX in Metastatic Colorectal Cancer
NCT01193517 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Oxaliplatin in Rectal Cancer
NCT00259363 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Neoadjuvant Treatment of Colon Cancer
NCT01108107 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer
NCT01729923 ·Status: TERMINATED ·Phase: PHASE2
-
Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.
NCT00337389 ·Status: UNKNOWN ·Phase: PHASE3
-
Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
NCT01006369 ·Status: COMPLETED ·Phase: PHASE2
-
Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
NCT00012389 ·Status: COMPLETED ·Phase: PHASE3
-
Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer
NCT00250835 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer
NCT00202774 ·Status: COMPLETED ·Phase: PHASE3
-
Utomilumab, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Metastatic Colorectal Cancer
NCT03290937 ·Status: COMPLETED ·Phase: PHASE1
-
Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer
NCT00571740 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal Cancer
NCT00422773 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal Cancer
NCT02848443 ·Status: COMPLETED ·Phase: PHASE1
-
Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma
NCT00625183 ·Status: TERMINATED ·Phase: PHASE2